DrugPatentWatch Database Preview

Epirubicin hydrochloride - Generic Drug Details

  Purchase this report

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for epirubicin hydrochloride and what is the scope of epirubicin hydrochloride freedom to operate?

Epirubicin hydrochloride is the generic ingredient in two branded drugs marketed by Pfizer Inc, Actavis Totowa, Akorn Inc, Cipla Ltd, Ebewe Pharma, Fresenius Kabi Oncol, Fresenius Kabi Usa, Hisun Pharm Hangzhou, Hospira, Impax Labs Inc, Mustafa Nevsat, Mylan Institutional, Mylan Labs Ltd, and West-ward Pharms Int, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for epirubicin hydrochloride. Nine suppliers are listed for this compound.

Summary for epirubicin hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	14
NDAs:	15
Drug Master File Entries:	9
Suppliers / Packagers:	9
Bulk Api Vendors:	69
Clinical Trials:	355
Patent Applications:	7,454
Formulation / Manufacturing:	see details
DailyMed Link:	epirubicin hydrochloride at DailyMed

Pharmacology for epirubicin hydrochloride

Ingredient-type	Anthracyclines
Drug Class	Anthracycline Topoisomerase Inhibitor
Mechanism of Action	Topoisomerase Inhibitors

Medical Subject Heading (MeSH) Categories for epirubicin hydrochloride

Antibiotics, Antineoplastic

Topoisomerase II Inhibitors

Synonyms for epirubicin hydrochloride

(1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside hydrochloride

(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside

(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside

(7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride

(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride

(7S,9S)-7-[(2R,4S,5R,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione

(7S,9S)-7-[[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

(8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride

(8S,10S)-10-(((2R,4S,5R,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione

(8S,10S)-10-{[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione

15206-EP2269994A1

15206-EP2270008A1

15206-EP2270018A1

15206-EP2272827A1

15206-EP2275420A1

15206-EP2280012A2

15206-EP2281815A1

15206-EP2289892A1

15206-EP2292615A1

15206-EP2292617A1

15206-EP2295055A2

15206-EP2295416A2

15206-EP2295426A1

15206-EP2295427A1

15206-EP2298748A2

15206-EP2298764A1

15206-EP2298765A1

15206-EP2298768A1

15206-EP2298778A1

15206-EP2298780A1

15206-EP2301928A1

15206-EP2301933A1

15206-EP2305640A2

15206-EP2305642A2

15206-EP2305671A1

15206-EP2305689A1

15206-EP2308855A1

15206-EP2308861A1

15206-EP2311453A1

15206-EP2311808A1

15206-EP2311825A1

15206-EP2311827A1

15206-EP2311829A1

15206-EP2311840A1

15206-EP2311842A2

15206-EP2316832A1

15206-EP2316833A1

22966TX7J5

25316-40-9

33811-EP2275420A1

33811-EP2295055A2

33811-EP2295416A2

33811-EP2298748A2

33811-EP2298764A1

33811-EP2298765A1

33811-EP2305642A2

33811-EP2311453A1

3Z8479ZZ5X

4-Epidoxorubicin

4-Epidoxorubicin hydrochloride

4'-epi-Adriamycin

4'-epi-Adriamycin hydrochloride

4'-epi-Doxorubicin

4'-epi-DX

4'-Epi-DXR

4'-Epiadriamycin

4'-epidoxorubicin

4'-Epidoxorubicin hydrochloride

4'-Epidoxorubicin|||4'-Epiadriamycin|||(8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione

5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-

5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-

5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabinohexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-

5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-

5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-

56390-09-1

56390-09-1 (hydrochloride)

56420-45-2

56420-45-2 (Parent)

57918-25-9

A831042

AB00698552_15

AB00698552_16

AB00698552-11

AB00698552-13

AB00698552-14

AC1L233G

AC1L26NP

AC1Q6JIV

Acid, 8

AK326115

AKOS027327569

AKOS030526162

AN-40147

AOJJSUZBOXZQNB-VTZDEGQISA-N

BC208841

BCP9000651

BDBM43839

BIFK0018

BRN 1445813

C11230

CA010514

CCG-100950

CCRIS 2261

CCRIS 4477

CHEBI:47898

CHEMBL1200981

CHEMBL417

CPD000466308

CS-1773

CS-2824

CTK8F9465

D02214

D07901

D0C9XJ

DB00445

Doxorubicin-13CD3 (discontinued)

DR003222

DTXSID0022987

E-ADM

Ebewe (TN)

EINECS 260-145-2

Ellence

Ellence (TN)

Epi-DX

Epiadriamycin

Epidoxorubicin

Epidoxorubicin hydrochloride

epirarubicin

Epirubicin

epirubicin (hydrochloride)

Epirubicin (INN)

Epirubicin (TN)

Epirubicin [INN:BAN]

Epirubicin Ebewe

Epirubicin HCl

Epirubicin HCl (4'-epidoxorubicin)

Epirubicin hydrochlorid

Epirubicin hydrochloride (JP17/USAN)

Epirubicin hydrochloride [USAN:JAN]

Epirubicin hydrochloride, >=90% (HPLC)

Epirubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard

Epirubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard

EPIRUBICIN(Hydrochloride form)

Epirubicina

Epirubicina [INN-Spanish]

Epirubicina [Spanish]

Epirubicine

Epirubicine [French]

Epirubicine [INN-French]

Epirubicinum

Epirubicinum [INN-Latin]

Epirubicinum [Latin]

Epirubitec

farmarubicin

farmarubicine

Farmorubicin

Farmorubicin (TN)

Farmorubicina

FT-0630692

HSDB 6962

HY-13624

HY-13624A

IMI 28

IMI-28

LS-187190

LS-93989

LS-93992

MFCD00941448

MLS000759412

MLS001401404

MolPort-003-666-844

MWWSFMDVAYGXBV-FGBSZODSSA-N

NC00200

NCGC00263918-04

NSC 256942

NSC-256942

NSC-759195

NSC256942

NSC759195

Pharmakon1600-01505708

pharmarubicin

Pharmorubicin

Pharmorubicin (TN)

Pharmorubicin Pfs

Pidorubicin

Pidorubicina

Pidorubicina [INN-Spanish]

Pidorubicine

Pidorubicine [INN-French]

Pidorubicinum

Pidorubicinum [INN-Latin]

Q-101406

Ridorubicin

s1223

SAM001246559

SBI-0206890.P001

SCHEMBL3165

SCHEMBL8582

SMR000466308

SR-01000763557

SR-01000763557-3

Triferric doxorubicin

UNII-22966TX7J5

UNII-3Z8479ZZ5X

VA10821

WP 697

ZINC3938704

US Patents and Regulatory Information for epirubicin hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	EPIRUBICIN HYDROCHLORIDE	epirubicin hydrochloride	INJECTABLE;INJECTION	065343-004	Apr 19, 2007	AP	RX	No	No
West-ward Pharms Int	EPIRUBICIN HYDROCHLORIDE	epirubicin hydrochloride	INJECTABLE;INJECTION	065289-001	Jun 27, 2007	AP	RX	No	No
Impax Labs Inc	EPIRUBICIN HYDROCHLORIDE	epirubicin hydrochloride	INJECTABLE;INJECTION	065331-002	Aug 9, 2007	AP	RX	No	No
Ebewe Pharma	EPIRUBICIN HYDROCHLORIDE	epirubicin hydrochloride	INJECTABLE;INJECTION	065339-002	Dec 22, 2009		DISCN	No	No

  Purchase this report

see a sample report or, see our see our flat-rate plans

  Purchase this report

see a sample report or, see our see our flat-rate plans